Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Melinta Therapeutics, Inc. /new/ (CEMP) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Melinta Therapeutics, Inc. /new/. Table 2 shows the detailed insider transactions. This company's CIK number is 1461993.
Total stock buying since 2014: $195,047,384.
Total stock sales since 2014: $6,944,590.
Total stock option exercises since 2014: $543,676.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 0 | $0 | 13,000 | $72,436 | 50,000 | $0 |
| 2018 | 29,147,778 | $194,855,453 | 0 | $0 | 0 | $0 |
| 2017 | 5,000 | $14,720 | 1,193,060 | $4,084,523 | 0 | $0 |
| 2016 | 0 | $0 | 842 | $25,314 | 842 | $0 |
| 2015 | 4,830 | $86,231 | 81,200 | $2,762,317 | 122,389 | $526,366 |
| 2014 | 10,000 | $90,980 | 0 | $0 | 12,105 | $17,310 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-06 | 0 | $0 | 13,000 | $72,436 | 0 | $0 |
| 2019-05 | 0 | $0 | 0 | $0 | 50,000 | $0 |
| 2018-05 | 23,370,000 | $116,855,450 | 0 | $0 | 0 | $0 |
| 2018-01 | 5,777,778 | $78,000,003 | 0 | $0 | 0 | $0 |
| 2017-03 | 0 | $0 | 150,000 | $533,095 | 0 | $0 |
| 2017-01 | 5,000 | $14,720 | 1,043,060 | $3,551,428 | 0 | $0 |
| 2016-01 | 0 | $0 | 842 | $25,314 | 842 | $0 |
| 2015-12 | 0 | $0 | 10,000 | $302,713 | 10,000 | $22,799 |
| 2015-11 | 0 | $0 | 12,200 | $351,116 | 10,000 | $22,799 |
| 2015-10 | 4,830 | $86,231 | 0 | $0 | 0 | $0 |
| 2015-06 | 0 | $0 | 50,000 | $1,787,000 | 50,000 | $0 |
| 2015-05 | 0 | $0 | 9,000 | $321,488 | 37,389 | $284,268 |
| 2015-03 | 0 | $0 | 0 | $0 | 15,000 | $196,500 |
| 2014-05 | 10,000 | $90,980 | 0 | $0 | 12,105 | $17,310 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-06-27 | Johnson John (Chief Executive Officer) | Sale | 13,000 | 5.57 | 72,436 |
| 2019-05-22 | Johnson John | Option Ex | 50,000 | .00 | 0 |
| 2018-05-29 | Duffy Erin (Chief Scientific Officer) | Buy | 4,000 | 5.00 | 20,000 |
| 2018-05-29 | Cammarata Sue (Chief Medical Officer) | Buy | 4,000 | 5.00 | 20,000 |
| 2018-05-29 | Estrem Paul (Chief Financial Officer) | Buy | 10,000 | 5.00 | 50,000 |
| 2018-05-29 | Zaccardelli David (Director) | Buy | 40,000 | 5.00 | 200,000 |
| 2018-05-29 | Wechsler Daniel Mark (See Remarks) | Buy | 50,000 | 5.00 | 250,000 |
| 2018-05-29 | Ferro Kevin (Director) | Buy | 23,257,000 | 5.00 | 116,285,000 |
| 2018-05-25 | Gill David N (Director) | Buy | 5,000 | 6.09 | 30,450 |
| 2018-01-05 | Ferro Kevin (Director) | Buy | 5,777,778 | 13.50 | 78,000,003 |
| 2017-03-08 | Goldstein Dov A Md | Sale | 99,900 | 3.57 | 356,443 |
| 2017-03-07 | Goldstein Dov A Md | Sale | 50,100 | 3.53 | 176,652 |
| 2017-01-13 | Goldstein Dov A Md | Sale | 105,460 | 3.40 | 358,564 |
| 2017-01-06 | Goldstein Dov A Md | Sale | 437,600 | 3.64 | 1,592,864 |
| 2017-01-05 | Goldstein Dov A Md | Sale | 500,000 | 3.20 | 1,600,000 |
| 2017-01-03 | Gill David N (Director) | Buy | 5,000 | 2.94 | 14,720 |
| 2016-01-04 | Goldstein Dov A Md | Sale | 842 | 30.07 | 25,314 |
| 2016-01-04 | Goldstein Dov A Md | Option Ex | 842 | .00 | 0 |
| 2015-12-15 | Oldach David W. (Chief Medical Officer) | Sale | 1,778 | 30.00 | 53,340 |
| 2015-12-15 | Oldach David W. (Chief Medical Officer) | Option Ex | 1,778 | 2.28 | 4,053 |
| 2015-12-11 | Oldach David W. (Chief Medical Officer) | Sale | 8,222 | 30.33 | 249,373 |
| 2015-12-11 | Oldach David W. (Chief Medical Officer) | Option Ex | 8,222 | 2.28 | 18,746 |
| 2015-11-09 | Oldach David W. (Chief Medical Officer) | Sale | 12,200 | 28.78 | 351,116 |
| 2015-11-09 | Oldach David W. (Chief Medical Officer) | Option Ex | 10,000 | 2.28 | 22,799 |
| 2015-10-26 | Kong Garheng (Director) | Buy | 2,830 | 17.43 | 49,335 |
| 2015-10-26 | Dougherty Michael R (Director) | Buy | 2,000 | 18.45 | 36,896 |
| 2015-06-22 | Goldstein Dov A Md | Sale | 50,000 | 35.74 | 1,787,000 |
| 2015-06-22 | Goldstein Dov A Md | Option Ex | 50,000 | .00 | 0 |
| 2015-05-22 | Fernandes Prabhavathi (President and CEO) | Sale | 9,000 | 35.72 | 321,488 |
| 2015-05-22 | Fernandes Prabhavathi (President and CEO) | Option Ex | 37,389 | 7.60 | 284,268 |
| 2015-03-04 | Kent Richard S (Director) | Option Ex | 15,000 | 13.10 | 196,500 |
| 2014-05-23 | Johnson John (Director) | Buy | 10,000 | 9.10 | 90,980 |
| 2014-05-14 | Fernandes Prabhavathi (President and CEO) | Option Ex | 12,105 | 1.43 | 17,310 |
Insider trading activities including stock purchases, stock sales, and option exercises of CEMP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Melinta Therapeutics, Inc. /new/ (symbol CEMP, CIK number 1461993) see the Securities and Exchange Commission (SEC) website.